Mustang Bio, Inc. (MBIO)
0.5412
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Mustang Bio Total Liabilities (Quarterly) : 8.068M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.068M |
| March 31, 2026 | 7.986M |
| December 31, 2025 | 8.064M |
| September 30, 2025 | 9.59M |
| June 30, 2025 | 10.15M |
| March 31, 2025 | 11.30M |
| December 31, 2024 | 13.18M |
| September 30, 2024 | 15.85M |
| June 30, 2024 | 16.85M |
| March 31, 2024 | 19.54M |
| December 31, 2023 | 17.62M |
| September 30, 2023 | 16.56M |
| June 30, 2023 | 15.37M |
| March 31, 2023 | 43.79M |
| December 31, 2022 | 46.15M |
| September 30, 2022 | 44.51M |
| June 30, 2022 | 39.90M |
| March 31, 2022 | 39.63M |
| December 31, 2021 | 12.77M |
| September 30, 2021 | 12.49M |
| June 30, 2021 | 8.182M |
| Date | Value |
|---|---|
| March 31, 2021 | 8.461M |
| December 31, 2020 | 11.46M |
| September 30, 2020 | 9.652M |
| June 30, 2020 | 25.80M |
| March 31, 2020 | 22.76M |
| December 31, 2019 | 21.79M |
| September 30, 2019 | 21.39M |
| June 30, 2019 | 21.18M |
| March 31, 2019 | 22.01M |
| December 31, 2018 | 6.358M |
| September 30, 2018 | 4.522M |
| June 30, 2018 | 4.07M |
| March 31, 2018 | 5.448M |
| December 31, 2017 | 3.661M |
| September 30, 2017 | 2.792M |
| June 30, 2017 | 4.762M |
| March 31, 2017 | 0.811M |
| December 31, 2016 | 3.223M |
| September 30, 2016 | 7.796M |
| June 30, 2016 | 6.165M |
| March 31, 2016 | 5.032M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.61M |
| Shareholders Equity (Quarterly) | 7.545M |
| Current Ratio | 1.972 |